maralixibat 10 MG Oral Tablet

RxCUI: 2712463
RxNorm name: maralixibat 10 MG Oral Tablet
Display name: maralixibat 10 MG Oral Tablet
Full name: maralixibat 10 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Livmarli	MARALIXIBAT CHLORIDE	Mirum Pharmaceuticals Inc.	64000394-1ef6-4e76-8ba8-11f25ba1b167	2025-04-10	Warnings, Adverse reactions	Exact identifier rxcui: 2712463

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
64000394-1ef6-4e76-8ba8-11f25ba1b167	maralixibat 10 MG Oral Tablet	PSN	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410
64000394-1ef6-4e76-8ba8-11f25ba1b167	maralixibat 10 MG Oral Tablet	SCD	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410
64000394-1ef6-4e76-8ba8-11f25ba1b167	10 MG (equivalent to maralixibat chloride 10.5 MG) Oral Tablet	SY	11	These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021	20250410